What is ATNF stock price today?

Visit our real-time dashboard for the current ATNF stock price and live market data.

Is ATNF stock going up or down today?

ATNF stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ATNF stock now?

The decision to buy ATNF depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ATNF a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ATNF based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ATNF stock overvalued or undervalued?

Use our DCF valuation calculator to determine if ATNF is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is ATNF's P/E ratio?

P/E ratio data for ATNF will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is ATNF's market cap?

ATNF (180 Life Sciences Corp) has a market capitalization of $1.08 billion, making it a small-cap stock.

What is ATNF's price to book ratio?

Price-to-book ratio for ATNF is available on our dashboard along with other valuation metrics.

Does ATNF pay dividends?

ATNF does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is ATNF's dividend yield?

ATNF does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is ATNF stock a good long-term investment?

ATNF's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ATNF's revenue growth rate?

Revenue growth data for ATNF is available on our dashboard with detailed financial statement analysis.

Profitability metrics for ATNF are available on our dashboard with complete income statement analysis.

What are the risks of investing in ATNF?

Key risks for ATNF include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ATNF compare to its competitors?

Compare ATNF to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ATNF's performance and positioning.

What is ATNF's stock price target for 2026?

Visit our prediction page for AI-powered price targets for ATNF with bull, base, and bear case scenarios.

What do analysts say about ATNF?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ATNF. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ATNF's next earnings report?

ATNF reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ATNF - 180 Life Sciences Corp

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About 180 Life Sciences Corp

180 Life Sciences Corp (ATNF) common stock

Price Chart

Loading chart...

ATNF Key Statistics

Market Cap

$1.08B

How ATNF Compares to Peers

ATNF is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 4

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 5

Company	Market Cap	P/E	Growth	Margin	Compare
ATNF(This stock)	$1.08B	N/A	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN

Data Updated: June 11, 2026 at 10:05 AM EDT

Ready to invest in ATNF?

Commission-free trading available. Affiliate links.

Upcoming Events for ATNF

Dashboard

Enter a ticker to analyze